Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: The role of adp and products of the cyclooxygenase pathway
- 1 November 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 40 (3) , 359-372
- https://doi.org/10.1016/0049-3848(85)90271-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Characteristics of the synergistic actions of platelet agonistsBlood, 1981
- Positive Interaction between Agonists in the Aggregation Response of Human Blood Platelets: Interaction between ADP, Adrenaline and VasopressinBritish Journal of Haematology, 1980
- Synergism between platelet aggregating agents: The role of the arachidonate pathwayThrombosis Research, 1977
- Arachidonic acid-induced human platelet aggregation and prostaglandin formationProstaglandins, 1973
- Platelet aggregation and release: effects of low concentrations of thrombin or collagenAmerican Journal of Physiology-Legacy Content, 1973
- Potentiation of the ADP-induced platelet aggregation by collagen and its inhibition by a tetrahydrothienopyridine derivative (Y-3642)Biochemical Pharmacology, 1971
- Effects of adrenaline on human blood plateletsThe Journal of Physiology, 1967
- Platelet Aggregation by ADP and ThrombinNature, 1966
- Influence of Catecholamines on Nucleotide-induced Platelet AggregationNature, 1966
- A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitorsJournal of Clinical Pathology, 1964